Merck Reiterates Confidence in Returning to Sustainable Growth

Tailwind thanks to robust global growth trends in all three business sectors

18-Oct-2024 - Merck is looking confidently toward the future. At the Capital Markets Day, the company shared its expectation of profitable and financially strong growth in the coming years. After the transitional year of 2023, Merck considers the medium-term growth opportunities in its markets to be intact. ...

Merck Welcomes Ten New Startups to its Innovation Center

17-Jan-2019 - Merck announced the ten startups that will be joining the seventh intake of its Accelerator program at the Merck Innovation Center in Darmstadt. The teams come from nine different countries, making 2019 the most international intake in the Merck Accelerator’s history. They were chosen from a ...

Merck Signs Strategic Alliance With Archemix

13-Jun-2007 - Merck KGaA announced that it has formed a multi-year strategic alliance between its Merck Serono division and Archemix Corp. of Cambridge, Massachusetts, to discover, develop and commercialize first-in-class aptamer therapeutics with a primary focus on the treatment of cancer. Additional areas of ...

Bernd Reckmann Appointed to the Executive Board of Merck KGaA

28-Sep-2006 - E. Merck OHG has appointed Dr. Bernd Reckmann as a General Partner and Member of the Executive Board of Merck KGaA effective January 1, 2007. Bernd Reckmann (50) will be responsible for Production (Polyproduction and Site Management Darmstadt and Gernsheim), Process Development, Engineering, ...

Merck KGaA Names New Leaders Within Ethicals Division and Corporate Development

08-Nov-2005 - Merck KGaA announced organizational changes on the commercial side of its Ethicals division, creating two main sections Commercial Unit CardioMetabolic Care & Operations and Commercial Unit Oncology. Christian Velmer joined Merck on November 1, 2005, as Senior Vice President responsible for the ...

Merck KGaA Purchases Spanish Pharmaceutical Business Prasfarma

15-Sep-2005 - Merck KGaA announced that its Spanish subsidiary Merck Genericos SL has purchased the pharmaceutical business of Prasfarma from Almirall Prodesfarma SA, for EUR 20 million, including inventories and other working capital. "A key element of our strategy in Europe is to expand in fast growing ...

Merck announces R&D restructuring after the decision to discontinue the diabetes projekt

02-Jun-2003 - In a strategic move to focus clinical development resources even more strongly on its Oncology pipeline, Merck KGaA announced today that the company has decided to discontinue further development of two early-stage Diabetes projects. The decision involves EML 16336, an insulin mimetic that ...

Merck KGaA Selects Jena, Germany, As Site For Planned Protein Production Plant

04-Mar-2003 - Merck KGaA announced today that the company will focus its planning efforts for a new large-scale production plant for therapeutic proteins on Jena in the German State of Thuringia. The decision was announced jointly on Monday by Thuringia's Prime Minister, Dr. Bernhard Vogel, and the Chairman ...

Merck KGaA Completes Acquisition of Kyowa Hakko's Mohan Generics

13-Mar-2002 - March 12, 2002 Darmstadt, Germany - Merck KGaA announced today that it has completed the acquisition of the generics drug company Mohan Medicine Research Institute of Tokyo from Kyowa Hakko Kogyo Co. Ltd. This will allow Merck to expand in the world's second-largest pharmaceutical market. ...